Cosmo Pharmaceuticals N.V. announced that Luigi Moro, its Chief Scientific Officer, is retiring and that Roberto Camerini MD will assume his responsibilities as of January 1, 2020. Roberto Camerini MD joined Cosmo in December 2018. He was formerly Director of Pre-Clinical and Clinical Research and Development at Alfa Wassermann S.p.A. from 2015 to 2018, and Head of Corporate Clinical Research at Sigma Tau S.p.A. Previously he worked for Serono and Abbot.